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Introduction. Myxomatosis	 is	 a	 major	 vi-
ral	 diseases	 of	 European	 rabbit	 (Oryctolagus 
cu ni culus),	 characterized	 by	 extensive	 internal	
and	 external	 lesions,	 immunodysfunction	 and	
bacterial	complications	(OIE,	2012).	Myxomatosis	
is	produced	by	Myxoma virus	 (MYXV),	a	poxvirus	
that	 produce	 a	 benign	 cutaneous	 fibroma	 in	 his	
natural	 hosts	 (Silvilagus	 spp.)	 (Kerr	 and	 Best,	
1998;	 McClure,	 2011).	 Along	 with	 the	 rabbit	
haemorrhagic	disease,	myxomatosis	is	one	of	the	
two	lagomorphs	diseases	included	in	the	Manual	
of	 Diagnostic	 Tests	 and	 Vaccines	 for	 Terrestrial	








upon	 the	 rabbit	 resistance	 development	 and	 the	
virus	 attenuation,	 the	 mechanisms	 of	 resistance	
or	 attenuation	 is	 very	 little	 understood.	 In	 this	
context	 the	 presence	 or	 circulation	 of	 MYXV	 is	
becoming	more	 difficult	 to	 identify	 on	 the	 basis	
of	clinical	surveillance.	For	this	reason	the	active	
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surveillance	 of	 myxomatosis	 throughout	 the	
country	should	be	considered.




Materials and methods. 158	 rabbit	 blood	
samples	 were	 collected	 from	 subjects	 living	 in	
Ilfov,	Giurgiu	and	Dambovita	Counties	(Romania).	
40	 samples	 were	 from	 previously	 vaccinated	
rabbits,	 79	 samples	 from	 unvaccinated	 rabbits	
and	 39	 samples	 from	 rabbits	 with	 unknown	
history	of	vaccination.	The	samples	were	collected	
from	 rabbits	 that	 lived	 in	 areas	 with	 history	 of	
myxomatosis.	 It	 was	 used	 in	 our	 study	 an	 in-
house	 cELISA	 developed	 since	 2000	 at	 Istituto	
Zooprofilattico	 Sperimentale	 della	 Lombardia	 e	
dell’Emilia	Romagna	“B.	Umbertini”	Brescia,	Italy	
(IZSLER)	by	Lavazza	and	Capucci.	
Results and Discussion. All	 plates	 used	 in	
experiment	 worked	 properly	 and	 the	 reaction	
controls	 provided	 expected	 results,	 with	
sensitivity	 and	 specificity	 similar	 to	 the	 ones	 of	
previous	 studies	 (Lavazza	 and	 Capucci,	 2008).	




total	 serum	 samples	 tested	3.16%	 (5/158)	were	
un-conclusive	 (recommendation	 for	 retesting),	
27.85%	(44/158)	positive	and	68.99%	(109/158)	
negative.	The	samples	from	previously	vaccinated	
rabbits	 revealed	 92.50%	 (37/40)	 positive	 and	
7.50%	 (3/40)	 negative	 results.	 The	 samples	
from	unvaccinated	 rabbits	were	 5.06	 (4/79)	 un-
conclusive,	 10.13%	 (8/79)	 positive	 and	 84.81	
(67/79)	negative.	The	samples	from	rabbits	with	
unknown	 history	 of	 vaccination	 had	 no	 positive	
results,	 only	 2.56%	 (1/39)	 sample	 has	 un-
conclusive	 and	97.44%	(38/39)	negative	 results.	
The	un-conclusive	results	could	express	 the	 long	
period	 of	 antibody	 developing	 (highest	 titre	
after	20–60	days	postinfection)	 if	 the	rabbits	are	
vaccined	or	develop	nonlethal	forms	(OIE	,2008).	
Also,	 the	 negative	 results	 did	 not	 rule	 out	 the	
exposure	 to	virus	because	 the	antibody	 titer	 can	
decrease	below	threshold	after	6–8	months	in	the	
absence	of	reexposure	(OIE	,2008).
Conclusion. The	 positive	 results	 obtained	




rabbits	 with	 unknown	 history	 of	 vaccination	
claims	 that	 they	 did	 not	 receive	 immunization	
and	 they	was	not	exposed	 to	wild	 strain	neither.	
The	 negative	 results	 obtained	 in	 the	 group	 of	
vaccinated	rabbits	can	have	several	causes	and	a	
booster	could	be	considered.
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